-
Product Insights
NewLeukocyte Surface Antigen CD47 – Drugs In Development, 2024
The Leukocyte Surface Antigen CD47 pipeline drugs market research report outlays comprehensive information on the Leukocyte Surface Antigen CD47 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, Hematological Disorders, and Dermatology which include indications of Solid Tumor, Lymphoma, Diabetic Retinopathy, Sickle Cell Disease, Thalassemia, and Pyoderma Gangrenosum. It also reviews key players involved in Leukocyte...
-
Product Insights
NewInterleukin 2 Receptor Subunit Alpha – Drugs In Development, 2024
The Interleukin 2 Receptor Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Interleukin 2 Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Cardiovascular which include indications of Solid Tumor, Melanoma, Systemic Lupus Erythematosus, Autoimmune Disorders, Atopic Dermatitis (Atopic Eczema), Alopecia Areata, Pulmonary Arterial Hypertension, and Stroke....
-
Product Insights
NewPlasminogen – Drugs In Development, 2024
The Plasminogen pipeline drugs market research report outlays comprehensive information on the Plasminogen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Hematological Disorders, Dermatology, and Genetic Disorders which include indications of Acute Ischemic Stroke, Ischemic Stroke, Bleeding And Clotting Disorders, Hemostasis, Diabetic Foot Ulcers, and Congenital Plasminogen Deficiency. It also reviews key players involved in Plasminogen...
-
Product Insights
NewRetinoic Acid Receptor Gamma – Drugs In Development, 2024
The Retinoic Acid Receptor Gamma pipeline drugs market research report outlays comprehensive information on the Retinoic Acid Receptor Gamma targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Dermatology, Musculoskeletal Disorders, Respiratory, and Oncology which include indications of Acne Vulgaris, Hand Dermatitis, Musculoskeletal Disorders, Fibrosis, Bronchopulmonary Dysplasia, Idiopathic Pulmonary Fibrosis, Head And Neck Cancer, and Non-Small Cell Lung...
-
Product Insights
NewMelanocyte Stimulating Hormone Receptor – Drugs In Development, 2024
The Melanocyte Stimulating Hormone Receptor pipeline drugs market research report outlays comprehensive information on the Melanocyte Stimulating Hormone Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Dermatology, Gastrointestinal, and Oncology which include indications of Diabetic Retinopathy, Uveitis, Vitiligo, Unspecified Dermatological Disorders, Inflammatory Bowel Disease, Peritonitis, Melanoma, and Metastatic Melanoma. It also reviews key players involved...
-
Product Insights
NewGlutamate Receptor Ionotropic NMDA 2 – Drugs In Development, 2024
The Glutamate Receptor Ionotropic NMDA 2 pipeline drugs market research report outlays comprehensive information on the Glutamate Receptor Ionotropic NMDA 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Respiratory, and Dermatology which include indications of Schizophrenia, Post-Traumatic Stress Disorder (PTSD), Cardiac Arrest, Orthostatic Hypotension, Idiopathic Pulmonary Fibrosis, Chronic Cough, and Burns. It...
-
Product Insights
NewInterleukin 33 – Drugs In Development, 2024
The Interleukin 33 pipeline drugs market research report outlays comprehensive information on the Interleukin 33 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Dermatology, Immunology, and Genito Urinary System which include indications of Asthma, Chronic Obstructive Pulmonary Disease (COPD), Atopic Dermatitis (Atopic Eczema), Autoimmune Disorders, Inflammation, and Diabetic Nephropathy. It also reviews key players involved in...
-
Product Insights
NewG Protein Coupled Bile Acid Receptor 1 – Drugs In Development, 2024
The G Protein Coupled Bile Acid Receptor 1 pipeline drugs market research report outlays comprehensive information on the G Protein Coupled Bile Acid Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Dermatology, Immunology, and Infectious Disease which include indications of Type 2 Diabetes, Obesity, Atopic Dermatitis (Atopic Eczema), Inflammation, Unspecified Immunological Disorders, Sepsis,...
-
Product Insights
NewProtein Kinase C Theta Type – Drugs In Development, 2024
The Protein Kinase C Theta Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Theta Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Unspecified Cancer, Breast Cancer, Rheumatoid Arthritis, Inflammation, Obesity, Type 2 Diabetes, and Atopic Dermatitis (Atopic Eczema). It also...
-
Product Insights
NewDual Specificity Tyrosine Phosphorylation Regulated Kinase 1B – Drugs In Development, 2024
The Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1B pipeline drugs market research report outlays comprehensive information on the Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Metabolic Disorders, Dermatology, and Non Malignant Disorders which include indications of Colorectal Cancer, Non-Small Cell Lung Cancer, Obesity, Cellulite, Benign Tumor, and Adiposis...